The conversation is about trying unconventional treatments for hairloss, such as green tea, coffee, cocoa, multivitamin pills, red wine, onion, honey, herbs, and hydrogen peroxide. The user is seeking feedback on these methods to avoid ineffective ones.
The conversation provides a guide on using finasteride for hairloss, suggesting to start with a quarter of a 1mg pill daily after ensuring estradiol levels are within a specific range, and potentially increasing the dose if no side effects occur. It also recommends supplements like DIM, Calcium d-glucarate, and Zinc to manage high estradiol levels and side effects from finasteride.
The user has been using Finasteride and Minoxidil for hairloss but has seen no progress. Suggestions include trying Dutasteride, increasing Minoxidil dosage, or considering a hair transplant.
The conversation discusses improvements to a platform and mentions hairloss treatments including Minoxidil, finasteride, RU58841, and melatonin. It also highlights the addition of features like Google login, reply by email, keyword extraction, and a term glossary for better understanding of hair-related terminologies.
The conversation discusses the progress of Clascoterone (Breezula) for hairloss treatment, noting that COVID-19 delayed female trials by three months but Phase III trials for males are proceeding with a Special Protocol Assessment filed with the FDA. Users express hope for Breezula as an alternative to existing treatments like finasteride and minoxidil, despite concerns about its potential high cost.
A 24-year-old male using dutasteride for hairloss is worried about its effects on fertility and future children's health. Users advise consulting a doctor, possibly switching to finasteride, or stopping dutasteride before conception due to its impact on sperm count.
A user shared a 15-year experience using minoxidil and finasteride for hairloss, stating that despite never missing a dose, their hairline continued to recede slowly. Other users suggested that the hairloss might be exacerbated by the use of steroids and recommended considering other treatments like dutasteride and RU58841.
A user shared their positive experience with finasteride and minoxidil for hairloss, noting significant improvement and regrowth after 1.5 years of treatment, despite initial side effects. They are now happy with their hair and personal life.
The conversation discusses whether to use finasteride for hairloss, considering its role in inhibiting DHT and 5AR, which can affect brain function and mood. Some users report anxiety and depression from finasteride, while others do not experience these side effects and emphasize the importance of DHT for brain and prostate health.
The conversation is about the role of vitamin deficiencies in hairloss and the effectiveness of treatments like Minoxidil, finasteride, and RU58841. It concludes that while vitamins and nutrition are important, they are not the primary solution for androgenic alopecia.
The conversation is about differing experiences with finasteride for hairloss, with some users reporting side effects and others not, and the debate over the drug's safety and effectiveness. Specific treatments mentioned include finasteride, dutasteride, and topical finasteride.
The user has been using a strong combination of hairloss treatments for 16 months, including Finasteride, Minoxidil, Dutasteride, and RU-58841, but their hairloss has worsened. They're questioning whether their high testosterone levels or residual scalp DHT are causing further hairloss, with a reply suggesting that even small amounts of DHT can cause hairloss if one is sensitive to it.
The conversation is about young men under 20 experiencing hairloss. They discuss their experiences and treatments used, including finasteride (fin) and minoxidil (min).
A user started taking 0.625mg oral minoxidil daily for hairloss, increased the dose to 1.25mg, and experienced a significant shed, losing 70% of scalp density. They cannot tolerate finasteride due to side effects but are hopeful for hair regrowth despite the shedding.
A user who has been trying various treatments for hairloss for four years, with no success. Suggestions include use of minoxidil, finasteride, RU58841, microneedling, supplements and multivitamins, lifestyle changes, scalp biopsy, and SMP.
The conversation is about frustration with dermatologists not effectively treating hairloss and the difficulty in obtaining prescriptions for Minoxidil and Finasteride. Some users suggest seeing specialists or general practitioners for hairloss treatment, while others share their own experiences with dermatologists and the importance of doing personal research.
The conversation discusses various celebrities who reportedly use hairloss treatments like finasteride and dutasteride. Users share their experiences and opinions on starting treatment, with some encouraging the original poster to consult a dermatologist and consider treatment before it's too late.
A 20-year-old started taking finasteride for hairloss at 18, saw improvement, but developed erectile dysfunction (ED) after taking accutane. Despite stopping both medications, ED persisted, and hairloss worsened. Advice given includes considering tadalafil for ED, resuming finasteride, using minoxidil, and addressing psychological factors through positive thinking and lifestyle changes.
The conversation discusses the potential of a new hairloss treatment, GT20029, which may prevent hairloss by destroying androgen receptors on the scalp. Users express hope for the treatment's success and speculate on its usage routine, effectiveness, and possible side effects.
The user experienced significant hair regrowth after three months of using 5 mg oral minoxidil nightly and plans to add finasteride to maintain progress. Many recommend combining minoxidil with finasteride or dutasteride to prevent future hairloss.
A user reports experiencing insomnia as a side effect of taking finasteride for hairloss, which takes 1 to 2 hours to fall asleep and results in only about 5 hours of sleep per night. They suspect the cause is related to the downregulation of neurosteroids due to finasteride.
Follicopeptide (FOL005) by Coegin Pharma will launch as a cosmetic hair growth treatment by Q2 2025, showing similar efficacy to finasteride. Users discuss the benefits and skepticism of releasing hairloss treatments as cosmetics rather than drugs.
A user is starting topical finasteride and minoxidil 3 times a week for hairloss and is experiencing high anxiety about the treatment's effectiveness and potential side effects. They are also taking vitamin D3 daily and are concerned about the application method and possible shedding.
A gel of keratin microspheres promotes hair follicle growth, showing similar effectiveness to minoxidil in mice. The treatment activates hair growth pathways and reduces inflammation, with potential applications in drug delivery for hair-related disorders.
A 22-year-old is frustrated with friends and family's dismissive attitudes towards hairloss and finds support and hope in an online community. They have not yet treated their hairloss but are considering medications like minoxidil and finasteride.
A 19-year-old is distressed about his 17-year-old autistic brother's hairloss, projecting his own insecurities despite being on finasteride and dutasteride. Replies suggest the brother might not care about balding, and the poster should address his own issues.
The user is experiencing a second hair shedding phase and increased flaking and itching while using minoxidil 5% nightly and microneedling every two weeks, with needle length increasing over time. Other users suggest the hairloss may continue without the use of finasteride.
The conversation suggests that people should consult a dermatologist to understand their type of hairloss before starting treatments like finasteride or dutasteride, especially if they have autoimmune issues or low DHT. Some participants believe in starting treatment like finasteride immediately if hairloss is due to DHT, while others recommend ruling out other causes and considering minoxidil first, especially for younger individuals.